Non-invasive prediction of the degree of liver fibrosis in patients with hepatitis C using an ultrasound contrast agent. A pilot study

Journal of Medical Imaging and Radiation Oncology

Volumn 52, Issue 2, 2008, Pages 130-133

  Searle, J ^a   Mendelson, R ^b   Zelesco, M ^b   Sanford, J ^b   Cheng, W ^b   McKinstry, C ^a   Ramsay, D ^b  

^a CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Hepatitis C; Liver circulation; Microbubble; Ultrasound

Indexed keywords

CONTRAST MEDIUM;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; HEPATIC ARTERY; HEPATIC VEIN; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MICROBUBBLE; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOLOGY DEPARTMENT; REPRODUCIBILITY; SPECTROSCOPY;

ALBUMINS; CONTRAST MEDIA; FLUOROCARBONS; HEPATITIS C; HUMANS; LIVER; LIVER CIRCULATION; LIVER CIRRHOSIS; MICROBUBBLES; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 41149180689     PISSN: 17549477     EISSN: 17549485     Source Type: Journal    
DOI: 10.1111/j.1440-1673.2008.01930.x     Document Type: Article

References (15)

1. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999 6 : 35 47.
2. Global Burden of Hepatitis C Working Group. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 2004 44 : 20 29.
3. Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004 39 : 1147 71.
4. Tobkes AI, Nord HJ. Liver biopsy: review of methodology and complications. Dig Dis 1995 13 : 267 74.
5. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003 38 : 1449 57.
6. Maharaj B, Maharaj RJ, Leary WP et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986 1 : 523 5.
7. Regev A, Berho M, Jeffers LJ et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002 97 : 2614 18.
8. Lackner C, Struber G, Liegl B et al. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology 2005 41 : 1376 82.
9. Fontana RJ, Lok AS. Noninvasive monitoring of patients with chronic hepatitis C. Hepatology 2002 36 : S57 64.
10. Schneider AR, Teuber G, Kriener S, Caspary WF. Noninvasive assessment of liver steatosis, fibrosis and inflammation in chronic hepatitis C virus infection. Liver Int 2005 25 : 1150 55.
11. Lim AK, Patel N, Eckersley RJ et al. Can Doppler sonography grade the severity of hepatitis C-related liver disease? AJR 2005 184 : 1848 53.
12. Bernatik T, Strobel D, Hahn EG, Becker D. Doppler measurements: a surrogate marker of liver fibrosis? Eur J Gastroenterol Hepatol 2002 14 : 383 7.
13. Lim AK, Taylor-Robinson SD, Patel N et al. Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C. Gut 2005 54 : 128 33.
14. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996 24 : 289 93.
15. Siddique I, El-Naga HA, Madda JP, Memon A, Hasan F. Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection. Scand J Gastroenterol 2003 38 : 427 32.